Pregnancy outcomes in women with type 1 diabetes using insulin degludec
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00592-021-01845-0.pdf
Reference32 articles.
1. Bacon S, Feig DS (2018) Glucose targets and insulin choice in pregnancy: what has changed in the last decade? Curr Diab Rep 18:77
2. de Jong J, Garne E, Wender-Ozegowska E, Morgan M, de Jong-van den Berg LT, Wang H (2016) Insulin analogues in pregnancy and specific congenital anomalies: a literature review. Diabetes Metab Res Rev 32:366–375
3. Mathiesen ER, Damm P, Jovanovic L et al (2011) Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev 27:543–551
4. Mathiesen ER, Hod M, Ivanisevic M et al (2012) Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 35:2012–2017
5. Mathiesen ER, Ali N, Alibegovic AC et al (2021) Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world EVOLVE study. Diabetes Care 44:2069
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin degludec in pregestational diabetes: evidence and perspectives;Archives of Medical Science – Atherosclerotic Diseases;2024-05-10
2. Emerging need of delivery systems for plant metabolites;Drug-delivery Systems of Phytochemicals and Therapeutic Strategies in Cancer Therapy;2024
3. Preconception Care for Individuals with Diabetes;EMJ Diabetes;2023-11-16
4. Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets;The Lancet Diabetes & Endocrinology;2023-07
5. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial;The Lancet Diabetes & Endocrinology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3